Analysis of VUS reporting, variant reinterpretation and recontact policies in clinical genomic sequencing consent forms
- 24 August 2018
- journal article
- research article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 26 (12) , 1743-1751
Abstract
There are several key unsolved issues relating to the clinical use of next generation sequencing, such as: should laboratories report variants of uncertain significance (VUS) to clinicians and/or patients? Should they reinterpret VUS in response to growing knowledge in the field? And should patients be recontacted regarding such results? We systematically analyzed 58 consent forms in English used in the diagnostic context to investigate their policies for (a) reporting VUS, (b) reinterpreting variants, including who should initiate this, and (c) recontacting patients and the mechanisms for undertaking any recontact. One-third (20/58) of the forms did not mention VUS in any way. Of the 38 forms that mentioned VUS, only half provided some description of what a VUS is. Approximately one-third of forms explicitly stated that reinterpretation of variants for clinical purposes may occur. Less than half mentioned recontact for clinical purposes, with variation as to whether laboratories, patients, or clinicians should initiate this. We suggest that the variability in variant reporting, reinterpretation, and recontact policies and practices revealed by our analysis may lead to diffused responsibility, which could result in missed opportunities for patients or family members to receive a diagnosis in response to updated variant classifications. Finally, we provide some suggestions for ethically appropriate inclusion of policies for reporting VUS, reinterpretation, and recontact on consent forms.Keywords
This publication has 29 references indexed in Scilit:
- Reporting practices for variants of uncertain significance from next generation sequencing technologiesEuropean Journal of Medical Genetics, 2017
- Unsolved challenges in pediatric whole-exome sequencing: A literature analysisCritical Reviews in Clinical Laboratory Sciences, 2016
- Erratum: Guidelines for diagnostic next-generation sequencingEuropean Journal of Human Genetics, 2016
- The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical GeneticistsJournal of Medical Genetics, 2015
- Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variantsProceedings of the National Academy of Sciences, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Clinical whole-exome sequencing: are we there yet?Genetics in Medicine, 2014
- Clinical utility of genetic testing in pediatric drug-resistant epilepsy: A pilot studyEpilepsy & Behavior, 2014
- ACMG clinical laboratory standards for next-generation sequencingGenetics in Medicine, 2013
- Whole-genome sequencing in health careEuropean Journal of Human Genetics, 2013